These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 2834499

  • 21. Haemodialysis with low MW heparin: dosage requirements for the elimination of extracorporeal fibrin formation.
    Lane DA, Ireland H, Flynn A, Anastassiades E, Curtis JR.
    Nephrol Dial Transplant; 1986; 1(3):179-87. PubMed ID: 2955253
    [Abstract] [Full Text] [Related]

  • 22. Anticoagulant effect at the time of epidural catheter removal in patients receiving twice-daily or once-daily low-molecular-weight heparin and continuous epidural analgesia after orthopedic surgery.
    Douketis JD, Kinnon K, Crowther MA.
    Thromb Haemost; 2002 Jul; 88(1):37-40. PubMed ID: 12152674
    [Abstract] [Full Text] [Related]

  • 23. Dose response relationships of anticoagulant activities after subcutaneous administration of two low molecular weight heparins in healthy individuals.
    Hellstern P, Kiehl R, von Blohn G, Köhler M, Meierhenrich U, Wenzel E.
    Thromb Haemost; 1986 Oct 21; 56(2):225-8. PubMed ID: 3810557
    [Abstract] [Full Text] [Related]

  • 24. [Plasma exchange with very low molecular weight heparin CY 222. Biological profile and therapeutic value].
    Assogba U, Crespo B, Bayrou B, Binet JL, Rottembourg J.
    Ann Med Interne (Paris); 1988 Oct 21; 139 Suppl 1():66-8. PubMed ID: 2854713
    [Abstract] [Full Text] [Related]

  • 25. Monitoring of heparin and low molecular weight heparin with capillary and venous whole blood.
    Harenberg J, Giese C, Dempfle CE, Stehle G, Heene DL.
    Thromb Haemost; 1988 Dec 22; 60(3):377-81. PubMed ID: 2853458
    [Abstract] [Full Text] [Related]

  • 26. Rationale for the use of a low molecular weight heparin during hemodialysis with polysulphone membrane in uremic patients.
    Moia M, Graziani G, Tenconi PM, Martinelli I, Ponticelli C.
    Ann Ital Med Int; 1997 Dec 22; 12(2):67-71. PubMed ID: 9284597
    [Abstract] [Full Text] [Related]

  • 27. Comparison of anticoagulation efficacy and clinical safety between imported and domestically manufactured low-molecular-weight heparin during hemodialysis.
    Liu ZQ, Wang L.
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Oct 22; 22(10):942-3. PubMed ID: 12377628
    [Abstract] [Full Text] [Related]

  • 28. Low molecular weight heparin and haemodialysis: neutralization by protaminchloride.
    Andrassy K.
    Blood Coagul Fibrinolysis; 1993 Dec 22; 4 Suppl 1():S39-43. PubMed ID: 8180328
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The activity of unfractionated heparin and low molecular weight heparins in rabbit plasma--the need for using absolute anti-factor Xa and antithrombin activities.
    Peyrou V, Béguin S, Boneu B, Hemker HC.
    Thromb Haemost; 1997 Feb 22; 77(2):312-6. PubMed ID: 9157588
    [Abstract] [Full Text] [Related]

  • 33. Inhibition of clot formation process by treatment with the low-molecular-weight heparin nadroparin in patients with carotid artery disease undergoing angioplasty and stenting. A thromboelastography study on whole blood.
    Konstantinidis K, Gerasimidis T, Verdy E, Elalamy I, Samama MM, Gerotziafas GT.
    Thromb Haemost; 2007 Jan 22; 97(1):109-18. PubMed ID: 17200777
    [Abstract] [Full Text] [Related]

  • 34. Prothrombinase-induced clotting time assay for determination of the anticoagulant effects of unfractionated and low-molecular-weight heparins, fondaparinux, and thrombin inhibitors.
    Calatzis A, Peetz D, Haas S, Spannagl M, Rudin K, Wilmer M.
    Am J Clin Pathol; 2008 Sep 22; 130(3):446-54. PubMed ID: 18701419
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Use of a low molecular weight heparin, CY 222, in the treatment of consumption coagulopathy].
    Audibert G, Lambert H, Toulemonde F, Alexandre P, Laprevote-Heully MC, Bollaert PE, Bauer P, Larcan A.
    J Mal Vasc; 1987 Sep 22; 12 Suppl B():147-51. PubMed ID: 2834489
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.